International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 153-158 doi: 10.5281/zenodo.16436991
Original Article
Comparative evaluation of the techniques of sutureless scleral fixation of posterior chamber intraocular lenses (SF-IOLs) with and without fibrin glue
 ,
 ,
 ,
 ,
 ,
 ,
Published
July 26, 2025
Abstract

PURPOSE - Clinical comparison between the techniques of sutureless SF- IOLs with and without fibrin glue in patients with deficient/absent capsular support.

METHODS - 40 patients were randomly divided into 2 groups: GROUP A - GLUED IOL– sutureless SF- IOL using fibrin glue. GROUP B- SUTURELESS IOL- sutureless SF-IOL without fibrin glue. Patients were evaluated in terms of surgical time, intraoperative difficulties, and postoperative complications, i.e. healing of the scleral flap, corneal clarity, anterior chamber reaction, post-op visual recovery, induced astigmatism, pupillary abnormalities, IOP changes and Centration of the IOL. Patients were followed up for a minimum of 6 months. Unpaired T test and 2-factor repeated measures ANOVA were used for statistical analysis.

RESULTS- The mean surgical time was longer in glued IOLs (48.50±0.05 min) than sutureless IOL group (43.75±13.06 min). (p=0.361). Postoperatively, the scleral flaps were well apposed and healthy in both groups. A significant rise in post-operative IOP was seen only in the glued IOL group (p=0.049).

CONCLUSIONS -  Sutureless SF-IOLs without glue not only avoid the cost of fibrin glue but are equally efficacious. The glued IOL group was associated with an increased incidence of secondary glaucoma, which may be due to multiple surgeries and pre- existing conditions in some patients.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
591 Views
279 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved